Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses
β Scribed by Yaling Zhou; Julie A. McEarchern; Edward Howard; Gary Pestano; Michael L. Salgaller; Marnix L. Bosch
- Publisher
- Springer-Verlag
- Year
- 2003
- Tongue
- English
- Weight
- 467 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0340-7004
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background Dendritic cells (DCs) are the most potent antigenβpresenting cells in initiating primary immune responses. Given the unique properties of DCs, geneβmodified DCs represent a particularly attractive approach for immunotherapy of diseases such as cancer. ## Methods Geneβmo
## Abstract Non small cell lung cancers (NSCLC) express cancer/testis antigens (CTA) genes and MAGEβA expression correlates with poor prognosis in squamous cell carcinomas. We addressed cytotoxic T lymphocytes (CTL) responses to HLA class I restricted CTA epitopes in TIL from NSCLC in an unselected
## Abstract Woodchucks infected with the woodchuck hepatitis virus (WHV) is the best available animal model for testing the immunotherapeutic effects of dendritic cells (DCs) in the setting of a chronic infection, as woodchucks develop a persistent infection resembling that seen in humans infected